Follow
Scott C. Garman
Title
Cited by
Cited by
Year
The molecular defect leading to Fabry disease: structure of human α-galactosidase
SC Garman, DN Garboczi
Journal of molecular biology 337 (2), 319-335, 2004
5332004
Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα
SC Garman, BA Wurzburg, SS Tarchevskaya, JP Kinet, TS Jardetzky
Nature 406 (6793), 259-266, 2000
5042000
The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags
DN Hebert, SC Garman, M Molinari
Trends in cell biology 15 (7), 364-370, 2005
3262005
Pediatric fabry disease
M Ries, S Gupta, DF Moore, V Sachdev, JM Quirk, GJ Murray, DR Rosing, ...
Pediatrics 115 (3), e344-e355, 2005
2932005
Crystal structure of the human high-affinity IgE receptor
SC Garman, JP Kinet, TS Jardetzky
Cell 95 (7), 951-961, 1998
2181998
Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: Biochemical characterization and restoration of normal intracellular …
S Ishii, HH Chang, K Kawasaki, K Yasuda, HL Wu, SC Garman, JQ Fan
Biochemical Journal 406 (2), 285-295, 2007
1802007
GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings
A Caciotti, SC Garman, Y Rivera-Colón, E Procopio, S Catarzi, L Ferri, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (7), 782-790, 2011
1682011
Poor immunogenicity of a self/tumor antigen derives from peptide–MHC-I instability and is independent of tolerance
Z Yu, MR Theoret, CE Touloukian, DR Surman, SC Garman, ...
The Journal of clinical investigation 114 (4), 551-559, 2004
1562004
CATALYTIC MECHANISM OF HUMAN Α-GALACTOSIDASE
AI Guce, NE Clark, EN Salgado, DR Ivanen, AA Kulminskaya, H Brumer, ...
Journal of Biological Chemistry 285 (6), 3625-3632, 2010
1532010
Structure of the human IgE-Fc Cε3-Cε4 reveals conformational flexibility in the antibody effector domains
BA Wurzburg, SC Garman, TS Jardetzky
Immunity 13 (3), 375-385, 2000
1302000
The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A
Y Rivera-Colón, EK Schutsky, AZ Kita, SC Garman
Journal of molecular biology 423 (5), 736-751, 2012
1262012
The 1.9 Å structure of α-N-acetylgalactosaminidase: molecular basis of glycosidase deficiency diseases
SC Garman, L Hannick, A Zhu, DN Garboczi
Structure 10 (3), 425-434, 2002
1092002
Structural basis of Fabry disease
SC Garman, DN Garboczi
Molecular genetics and metabolism 77 (1-2), 3-11, 2002
962002
The alpha-galactosidase A p. Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies
S Ferreira, A Ortiz, DP Germain, M Viana-Baptista, A Caldeira-Gomes, ...
Molecular genetics and metabolism 114 (2), 248-258, 2015
952015
The molecular basis of pharmacological chaperoning in human α-galactosidase
AI Guce, NE Clark, JJ Rogich, SC Garman
Chemistry & biology 18 (12), 1521-1526, 2011
922011
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study
DP Germain, E Brand, A Burlina, F Cecchi, SC Garman, J Kempf, ...
Molecular genetics & genomic medicine 6 (4), 492-503, 2018
882018
Structure–function relationships in α‐galactosidase A
SC Garman
Acta Paediatrica 96, 6-16, 2007
882007
The 1.51-Å structure of the poxvirus L1 protein, a target of potent neutralizing antibodies
HP Su, SC Garman, TJ Allison, C Fogg, B Moss, DN Garboczi
Proceedings of the National Academy of Sciences 102 (12), 4240-4245, 2005
802005
Role of conserved tyrosine residues in NiSOD catalysis: a case of convergent evolution
RW Herbst, A Guce, PA Bryngelson, KA Higgins, KC Ryan, DE Cabelli, ...
Biochemistry 48 (15), 3354-3369, 2009
772009
The 1.9 Å structure of human α-N-acetylgalactosaminidase: the molecular basis of Schindler and Kanzaki diseases
NE Clark, SC Garman
Journal of molecular biology 393 (2), 435-447, 2009
752009
The system can't perform the operation now. Try again later.
Articles 1–20